Analyst firms · Barclays · MET
Barclays MET price target and rating history
MetLife Inc. (MET) · Finance
Barclays rates MetLife Inc. (MET) Overweight with a $91 price target, as of its latest action on Sep 5, 2024. It has published 4 rating actions on MET since October 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a MET price target in the last 12 months, the median target is $101.
- Current rating
- Overweight
- Price target
- $91
- Median target, all firms
- $101
- Actions on MET
- 4
Barclays price target on MET
Every Barclays rating on MET
- Sep 5, 2024
- Nov 17, 2023
- Jan 11, 2022
- Oct 12, 2021
How other firms rate MET
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Overweight | $110 | Sep 22, 2026 |
| Evercore ISI | In-line | $97 | Jan 6, 2026 |
| Mizuho | Outperform | $101 | Dec 16, 2025 |
Questions about Barclays and MET
- What is Barclays's price target for MET?
- Barclays's latest stated price target for MetLife Inc. (MET) is $91, from its action on Sep 5, 2024.
- What is Barclays's rating on MET?
- Barclays rates MET Overweight, a bullish rating, as of Sep 5, 2024.
- When did Barclays last change its view on MET?
- On Sep 5, 2024, Barclays starts coverage at Overweight, price target $91.
- How does Barclays's MET target compare with other analysts?
- Across 3 firms with a MET price target in the last 12 months, the median target is $101.
More MET rating histories
All Barclays ratingsMET news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.